We are live on ! Find out more
AllianceBernstein

AllianceBernstein Portfolio holdings

AUM $309B
1-Year Est. Return 23.92%
 

AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.

This Fund
S&P 500
This Quarter Est. Return
-6.78%
1 Year Est. Return
+23.92%
3 Year Est. Return
+92.38%
5 Year Est. Return
+118.97%
10 Year Est. Return
+515.32%
AUM
$259B
AUM Growth
-$23.7B
Cap. Flow
+$1.72B
Cap. Flow %
0.66%
Top 10 Hldgs %
24.75%
Holding
3,400
New
107
Increased
1,503
Reduced
1,401
Closed
139

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$1.2B
2
ZBRA icon
Zebra Technologies
ZBRA
+$682M
3
ADSK icon
Autodesk
ADSK
+$664M
4
ENTG icon
Entegris
ENTG
+$646M
5
NKE icon
Nike
NKE
+$560M

Sector Composition

Rank Sector Weight
1 Technology 25.99%
2 Healthcare 16.08%
3 Consumer Discretionary 12.25%
4 Financials 11.95%
5 Industrials 9.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EEX
3151
DELISTED
Emerald Holding
EEX
$64K ﹤0.01%
18,900
APSG.WS
3152
DELISTED
Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer
APSG.WS
$64K ﹤0.01%
46,917
ANGI icon
3153
Angi Inc
ANGI
$244M
$63K ﹤0.01%
+1,112
New +$81.1K
SYRS
3154
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$63K ﹤0.01%
5,280
+20
+0.4% +$358
ACIC icon
3155
American Coastal Insurance
ACIC
$516M
$61K ﹤0.01%
18,400
IVVD icon
3156
Invivyd
IVVD
$173M
$61K ﹤0.01%
13,300
-8,200
-38% -$50.2K
TCRR
3157
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$61K ﹤0.01%
22,200
-5,100
-19% -$16K
BYSI icon
3158
BeyondSpring
BYSI
$47.3M
$60K ﹤0.01%
27,200
-4,000
-13% -$11.6K
IVC
3159
DELISTED
Invacare Corporation
IVC
$60K ﹤0.01%
42,600
-10,700
-20% -$22.9K
ACTG icon
3160
Acacia Research
ACTG
$449M
$59K ﹤0.01%
13,041
-2,800
-18% -$11.8K
IBIO icon
3161
iBio
IBIO
$68.6M
$59K ﹤0.01%
273
+1
+0.4% +$209
TME icon
3162
Tencent Music
TME
$15.3B
$59K ﹤0.01%
+12,095
New +$68K
NAGE
3163
Niagen Bioscience
NAGE
$258M
$59K ﹤0.01%
24,100
-5,200
-18% -$14.2K
NGD
3164
DELISTED
New Gold Inc
NGD
$57K ﹤0.01%
31,671
+9,571
+43% +$16.4K
ZVRA icon
3165
Zevra Therapeutics
ZVRA
$562M
$57K ﹤0.01%
11,400
SLDB icon
3166
Solid Biosciences
SLDB
$761M
$56K ﹤0.01%
3,113
-767
-20% -$13.5K
OLMA icon
3167
Olema Pharmaceuticals
OLMA
$981M
$53K ﹤0.01%
12,400
-3,300
-21% -$18.2K
FSM icon
3168
Fortuna Silver Mines
FSM
$2.51B
$52K ﹤0.01%
+13,566
New +$51.3K
AXDX
3169
DELISTED
Accelerate Diagnostics
AXDX
$51K ﹤0.01%
3,541
+10
+0.3% +$285
QTNT
3170
DELISTED
Quotient Limited Ordinary Shares
QTNT
$51K ﹤0.01%
1,053
-5,839
-85% -$349K
SYRE icon
3171
Spyre Therapeutics
SYRE
$8.22B
$50K ﹤0.01%
864
-160
-16% -$13.4K
PASG icon
3172
Passage Bio
PASG
$14.5M
$49K ﹤0.01%
785
ETNB
3173
DELISTED
89bio
ETNB
$48K ﹤0.01%
12,700
-1,300
-9% -$8.37K
ADTHW
3174
DELISTED
AdTheorent Holding Co Warrants
ADTHW
$48K ﹤0.01%
33,933
CCV.WS
3175
DELISTED
Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCV.WS
$48K ﹤0.01%
77,876

Similar funds

AllianceBernstein's Q1 2022 Portfolio in Review

As of Q1 2022, AllianceBernstein held 3,400 positions worth $259B, down 8.4% from $283B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

AllianceBernstein's Q1 2022 filing shows 107 new, 1,503 increased, 1,401 reduced and 139 closed positions. Its largest new stake was State Street Financial Select Sector SPDR ETF: 1,823,221 shares worth $69.9M. The largest sale was Meta Platforms (Facebook), an estimated $1.47B.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • AllianceBernstein's largest Q1 2022 buy was State Street Financial Select Sector SPDR ETF: 1,823,221 shares worth $69.9M.
  • AllianceBernstein added most to Advanced Micro Devices in Q1 2022, an estimated $1.2B increase.
  • AllianceBernstein's biggest Q1 2022 reduction was Meta Platforms (Facebook), cutting an estimated $1.47B.
  • AllianceBernstein fully exited Xilinx Inc in Q1 2022, selling an estimated $1.39B.
  • AllianceBernstein's ten largest holdings make up 25% of its $259B portfolio in Q1 2022.
  • AllianceBernstein opened 107 new positions and closed 139 in Q1 2022.
  • AllianceBernstein's portfolio value fell 8.4% quarter-over-quarter to $259B.

Based on AllianceBernstein's 13F filing for Q1 2022, filed 13 May 2022.